2022 Boston University Ophthalmology Update and Haimovici Symposium
Back in Person in Boston.
The 2022 Boston University Ophthalmology Update and Haimovici Symposium is designed for practicing ophthalmologists, optometrists, ophthalmic technicians and medical personnel involved in the diagnosis and treatment of eye disease. In this program, national and departmental experts will discuss the most advanced medical and surgical treatment options for ophthalmic conditions such as retinal diseases, neuro-ophthalmology, plastics, glaucoma, cornea, pediatric ophthalmology, strabismus and amblyopia This conference is designed to address gaps in knowledge and competence in these areas.
It also includes the Haimovici Lecture. Named in honor of Robert Haimovici, MD, beloved retina specialist who served as the Director of the Retina Service at Boston Medical Center and BUSM from 1994 until his death in 2002, this lecture honors his dedication and professionalism and his deep commitment to education.
COVID-19 Safety Precautions
Update 4/4 - Masks will be required in the meeting areas with the exception of the exhibitor and break areas where masks are encouraged but optional." All attendees will be expected to be up to date on COVID-19 vaccinations.
Please note we will be following all Boston University and City of Boston event and meeting protocols to ensure the health and safety of all attendees, staff, and the local community and will update all attendees on these protocols as we get closer to the meeting date. In person attendees must attest that they have been fully vaccinated (14 days since last dose) before attending the meeting and bring their vaccination card with them. If you will not be fully vaccinated or feel ill on the day, we respectfully ask that you do not attend (a refund will be issued)
This program is supported in part by educational grants from:
- Alcon Vision, LLC
- Genentech, Inc.
- Horizon Therapeutics USA , Inc.
- This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
The following will be exhibiting at the meeting:
- Alcon
- Allergan
- Glaukos
- Heidelberg Engineering, Inc.
- Horizon Therapeutics USA , Inc.
- New World Medical
- Sanofi
- SightSciences
Target Audience
This program is for ophthalmologists, optometrists, ophthalmic technicians, and the healthcare team involved in the diagnosis and treatment of eye disease.
Learning Objectives
At the end of this program, participants should be able to:
- Discuss the primaty outcomes of the Zoster Eye Disease Study.
- Discuss IOL options and updates in IOL technology
- Review complications unique to FLACS in order to provide the patients the best possible outcomes.
- Discuss the different types of MIGS procedures including how to incorporate MIGS into a comprehensive ophthalmology practice.
- Discuss updates in Humphrey Visual Field testing Strategies and visual field technology.
- Discuss updates in Optical Coherence Tomography (OCT)
- Discuss how these technologies are best used to facilitate care of glaucoma patients individually and in tandem
- Identify the new glaucoma medications and discuss when to use them and their adverse events.
- Choose and provide appropriate treatment for issues related to glaucoma.
- Identify risk factors for development of diplopia after implantation of hardware for management of glaucoma and retinal detachment.
- Identify pars planitis and features that necessitate treatment.
- Describe common eyelid masses including differentiating between benign and malignant eyelid lesions and their management options.
- Recognize distinguishing features of active thyroid eye disease (signs and symptoms) and become more familiar with indications for several of the treatment options available to TED patients.
- Discuss evidence-based treatment of diabetic retinopathy in the era of anti-vascular endothelial growth factor and improved imaging modalities.
- Compare results of clinical trials to real-world clinical practice in the treatment of age-related macular degeneration and diabetic retinopathy and highlight causes of discrepancies.
- Discuss novel strategies to reduce the treatment burden of intravitreal injections of anti VEGF medications for chorioretinal vascular disease
- Review of ocular imaging and protein biomarkers and the eye's potential role in diagnosis of Alzheimer's Disease.
- Review the impact and challenges in AMD.
- Review pathogenesis and risk factors of AMD
Friday, April 8, 2022 | |
12:15 PM | Registration |
1:00 PM | Welcome and Introduction - Stephen P. Christiansen, MD |
1:10 PM | ZEDS: the Zoster Eye Disease Study - Christine Ament MD |
1:25 PM | Choice Overload? IOL Selection Challenges – Rachel Robbin, MD |
1:40 PM | A Potpourri of FLACS Complications - Kambiz Negahban, MD |
2:25 PM | Break |
3:00 PM | Role of MIGS in Glaucoma Manangement: Hype or Real - Babak Eliassi-Rad, MD |
3:15 PM | OCT is Here, Do We Still Need Visual Fields? - Manishi A. Desai, MD |
3:30 PM | The Latest and Greatest Glaucoma Medications - Haben F. Kefella, MD, MHS |
3:45 PM | Glaucoma Panel - Babak Eliassi-Rad, MD, Manishi A. Desai, MD, Haben F. Kefella, MD, MHS |
4:00 PM | Restrictive Strabismus: Tubes and Buckles - Stephen P. Christiansen, MD |
4:15 PM | Pars Planitis: What it is and When to Treat It - KC LaMattina, MD |
4:30 PM | Eyelid Lumps and Bumps - Alberto Distefano, MD |
4:45 PM | When Graves Means Danger: Update on Thyroid Eye Disease - Anna C. Kupcha, MD |
5:00 PM | Adjourn/Reception |
Saturday, April 9, 2022 | |
7:15 AM | Registration and Continental Breakfast |
8:00 AM | Introduction - Babak Eliassi-Rad, MD |
8:05 AM | Update on Diabetic Retinopathy: How to Achieve 20/20 in 2022 - Nicole H. Siegel, MD |
8:20 AM | Reducing the Treatment Burden in Chorioretinal Vascular Disease - Steven Ness, MD |
8:35 AM | Ocular Biomarkers in Alzheimer’s Disease - Manju Subramanian MD, FACS |
8:50 AM | Haimovici Lecture Introduction - Edward B. Feinberg, MD, MPH |
8:55 AM | 2022 Haimovici Lecture: Novel Biomarkers of Age-Related Macular Degeneration - Deeba Husain MD |
9:35 AM | Haimovici Lecture Award |
9:45 AM | Break |
10:10 AM | Management of Age-Related Macular Degeneration - Deeba Husain, MD |
10:50 AM | Retina Fellow Case Presentations - Joshua Agranat, MD and Samaneh Davoudi, MD |
11:20 AM | Adjourn |
European soul and design at our Ink Block hotel in Boston
Connect to the city in a new way at AC Hotel Boston Downtown, a hotel in Boston, MA located at the intersection of past and present, revolution and academia, rich culture and sports-fueled pride. Thoughtful service & modern mindset define our hotel near Tufts University where every element is tailored for harmony in your Boston travels. Our amenities include European-inspired breakfast, free WiFi, 50-inch TVs, flexible workspace and mini-fridges. We also offer a 24-hour fitness center, business services, and meeting spaces for 5 to 140 guests. Find a great selection of quick snacks in the AC Store or join us in the AC Lounge for a nightly selection of tapas-inspired bites. Since we cater to travelers looking to immerse themselves in the energy of downtown, know that from our South End Boston hotel you’re minutes to the heart of the city – to attractions, theater, universities & convention centers, as well as the airport. Welcome to an elevated state of mind.
Program Directors
Stephen P. Christiansen, MD
Professor and Chair
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center
Babak Eliassi-Rad, MD
Director, Glaucoma Service
Assistant Professor of Ophthalmology
Boston University School of Medicine/Boston Medical Center
Faculty
Christine Ament, MD
Assistant Professor
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center
Joshua Agranat, MD
Fellow
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center
Samaneh Davoudi, MD
Fellow
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center
Manishi A. Desai, MD
Assistant Professor
Director of Glaucoma Fellowship
Director of International Education
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center
Alberto Distefano, MD
Assistant Professor, Department of Ophthalmology
Boston University School of Medicine
Director of Oculoplastic Reconstructive and Orbital Surgery
Neuro-ophthalmology
Deeba Husain MD
Associate Professor Ophthalmology
Harvard Medical School
Investigator Angiogenesis Laboratory
Retina Service
Massachusetts Eye and Ear Infirmary
Haben F. Kefella, MD, MHS
Assistant Professor
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center
Anna C. Kupcha, MD
Assistant Professor, Oculoplastics Service
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center
KC LaMattina, MD
Assistant Professor
Director of Uveitis Service
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center
Kambiz Negahban, MD
Assistant Professor
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center
Steven Ness, MD
Assistant Professor of Ophthalmology,
Boston University School of Medicine
Director of Retina Service,
Boston University Eye Associates
Attending Physician,
VA Boston Healthcare System
Rachel Robbins, MD
Assistant Professor
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center
Nicole Hauptman Siegel, MD
Vitreoretinal Disease and Surgery
Assistant Professor of Ophthalmology
Vice Chair of Education, Department of Ophthalmology
Program Director, Ophthalmology Residency
Boston University School of Medicine/Boston Medical Center
Manju Subramanian MD, FACS
Vitreoretinal Disease and Surgery
Associate Professor of Ophthalmology
Vice-Chair for Faculty Affairs
Boston University School of Medicine/Boston Medical Center
Program Manager
Claire P. Grimble, CMP
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program has been submitted to IJCAHPO for consideration of CE credit.
COPE Course ID: 77697-GO
Qualified Credit: 3.25 hour(s)
Course: 2022 Boston University Ophthalmology Update and Haimovici Symposium Day 1
COPE Activity ID#123764
COPE Course ID: 77701-TD
Qualified Credit: 2.25 hour(s)
Course: 2022 Boston University Ophthalmology Update and Haimovici Symposium Day 2
COPE Activity ID#123764
Available Credit
- 5.50 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 5.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 5.50 Participation
This program is supported in part by educational grants from:
- Alcon Vision, LLC
- Genentech, Inc.
- Horizon Therapeutics USA , Inc.
- This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
The following will be exhibiting at the meeting:
- Alcon
- Allergan
- Glaukos
- Heidelberg Engineering, Inc.
- Horizon Therapeutics USA , Inc.
- New World Medical
- Sanofi
- SightSciences
Price
Registration Fees
MD/DO Two Days | $250 |
MD/DO One Day | $125 |
BUSM/BMC Staff Two Days | $0 |
BUSM/BMC Staff One Day | $0 |
Allied Healthcare Two Days | $150 |
Allied Healthcare One Day | $75 |
BU/BMC Alumni are 20% off. Please use coupon code ALUMNI20 at checkout
To pay by check, please create an account and email us at cme@bu.edu or call 617-358-5005 and we will assist you.
Cancellation Policy
Substitutions may be made at any time without an additional charge. Refunds, less an $50 administrative fee, will be issued for all cancellations received two weeks prior to the start of the meeting. Should cancellation occur within the two-week window, a credit will be issued, not a refund. Credits will be honored for up to two years. “No shows” are subject to the full course fee. Cancellations/substitution(s) must be made in writing. Refunds or credits will not be issued once the conference has started. This course is subject to change or cancellation.
Special Services / Dietary Needs
Boston University strives to be accessible, inclusive and diverse in our facilities, programming and academic offerings. Your experience in this event is important to us. If you have a disability, require communication access services for the deaf or hard of hearing, or believe that you require a reasonable accommodation for another reason please contact the BUSM-CME Office at least 3 weeks prior to event to discuss your needs. For in person meetings with meals, we will work to accommodate dietary requests (including, but not limited to: kosher, vegetarian, low cholesterol, and low sodium) received in writing at least three weeks prior to the start of the conference. Please contact us at cme@bu.edu
Please Note
The conference organizers may take pictures or record videos during the conference. In registering for the conference, you acknowledge that BUSM may photograph you during the meeting, and you agree that we may include images of yourself, intact or in part, for conference promotional activities or other related endeavors. This material may also appear on the conference's website or associated social media outlets. If you do not wish to be photographed, please let the BUSM representative onsite know
COVID-19 Safety Precautions
Update 4/4 - Masks will be required in the meeting areas with the exception of the exhibitor and break areas where masks are encouraged but optional." All attendees will be expected to be up to date on COVID-19 vaccinations.
Please note we will be following all Boston University and City of Boston event and meeting protocols to ensure the health and safety of all attendees, staff, and the local community and will update all attendees on these protocols as we get closer to the meeting date. In person attendees must attest that they have been fully vaccinated (14 days since last dose) before attending the meeting. If you will not be fully vaccinated or feel ill on the day, we respectfully ask that you do not attend the meeting (a refund will be issued.)
Unauthorized Registration Sites
Registration for courses managed by BUSM-CME can only be completed through our website at https://cme.bu.edu. Course registrations made through other sites cannot be honored. BUSM-CME is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com
Please report any unauthorized websites or solicitations for registrations to cme@bu.edu.